Navigenics launches portal
to give doctors access to patients' genomic information
10 February 2009
Navigenics, a US personal genomics testing company, has developed an
online portal that allows doctors to access the genomic information of
consenting patients.
For patients choosing to receive a Navigenics service through their
physician, this portal allows the physician to integrate patients’
genetic information into personalized health plans designed to help
diagnose early or prevent a number of health conditions.
Accessible through Navigenics’ website, the secure portal empowers
physicians with a suite of tools including a single access point to all
of their participating patients’ genomic information, along with
learning tools and case studies for integrating genomic information into
their clinical practice.
Navigenics also announced that it has expanded its portfolio of DNA
testing services by offering a new service that provides a lower cost of
entry into genetic health. Called Navigenics Annual Insight, the new
service is available for US$499 and mirrors many of the hallmarks of the
company’s flagship product, Navigenics Health Compass, and provides
information on an individual’s genetic predisposition for common
preventable health conditions.
Physician portal
Navigenics has developed the ability for physicians, with the
approval of their patients, to receive and easily review patient genetic
results online, with easy access to condition information, action steps,
and original scientific research. Access to the physician portal is free
to physicians who register their practices.
“We believe that genetic information has the potential to have a
profound impact in enhancing patients’ lives,” said Vance Vanier, MD,
Navigenics Chief Medical Officer. “Because an individual’s primary
physician is the most important partner in maintaining good health and
preventing disease, we have made it a top priority to develop tools and
resources that can make it easier for a doctor to integrate genomic
medicine into their practice.”
In order to foster adoption of genetic information into the practice
of medicine, Navigenics has entered into research studies and
collaborations with various organizations, including the American
College of Preventive Medicine, Duke University Medical Center, The Mayo
Clinic, MDVIP and Scripps Translational Science Institute.
Annual Insight Service
Navigenics’ Annual Insight service analyzes an individual’s genetic
predisposition for ten common health conditions (nine each for men and
women), including breast cancer, prostate cancer, colon cancer and heart
disease. The service, which costs US$499, will be available to consumers
through participating healthcare providers or directly from the
Navigenics website with genetic counselor support.
The Navigenics Annual Insight service uses the same stringent
scientific and clinical criteria as Navigenics Health Compass, as well
as a CLIA-certified laboratory. The results are delivered to
individuals, or, if they choose, their healthcare providers, through a
secure website that includes information to help individuals take steps
to detect conditions early, reduce their effects or prevent them
entirely. The Navigenics Annual Insight service also includes one hour
of consultation time with a Navigenics’ board-certified Genetic
Counselor to help explain results and provide additional support.
Bookmark this page